MedTrace Logo

Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis

NCT03634787 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2018-08-16

No results posted yet for this study

Summary

To investigate the role of Heat Shock Proteins in the mechanism of acute severe pancreatitis. In addition to test the potential treatment target of acute pancreatitis.

All patients who present with clinical symptoms of acute pancreatitis are evaluated for the enrollment of the study.

Conditions

Interventions

DIAGNOSTIC_TEST

CT Scan Day 5-7

Computed Tomography on Day 5-7 according to a clinical protocol.

Sponsors & Collaborators

  • Vilnius University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2021-12-31
Completion
2021-12-30

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03634787 on ClinicalTrials.gov